States' Case No Bellwether In Price-Fixing MDL, Teva Says
By Jeannie O'Sullivan · March 13, 2020, 4:54 PM EDT
Teva Pharmaceuticals and other generic-drug makers slammed a special master's recommendation that an antitrust suit by multiple states and territories be the bellwether in Pennsylvania-based multidistrict litigation, arguing it gives an...
To view the full article, register now.